Phentermine (phentermine hydrochloride) NDC 13107-105

NDC codes

FDA NDC Directory

Product NDC (as listed)13107-105Labeler and product segments. Claims need a package NDC.

Product NDC at billing width13107-0105Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
13107-105-01	13107010501	100 CAPSULE in 1 BOTTLE (13107-105-01)Marketed from Mar 20, 2017
13107-105-30	13107010530	30 CAPSULE in 1 BOTTLE (13107-105-30)Marketed from Mar 20, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phentermine
Generic name (nonproprietary): phentermine hydrochloride
Active ingredients: Phentermine hydrochloride — 15 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Aurolife Pharma, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204318
Marketing start: Mar 20, 2017
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Appetite Suppression (Physiologic effect)Increased Sympathetic Activity (Physiologic effect)
Identifiers: Product ID 13107-105_53dd7857-41fb-4da1-88f7-5c68a509bfb0SPL ID 53dd7857-41fb-4da1-88f7-5c68a509bfb0SPL set ID 737eef3b-9a6b-4ab3-a25c-49d84d2a0197RxCUI 900038, 968766UNII 0K2I505OTV
Pharmacologic class: Sympathomimetic Amine Anorectic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N413107010501 followed by a unit qualifier and the quantity

Package 13107-0105-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 4, 2019.

Indications (excerpt from the label)

Phentermine hydrochloride Capsules are indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 30 kg/m 2 , or greater than or equal to 27 kg/m 2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). Below is a chart of body mass index (BMI) based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = k…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204318

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204318
Product	Strength	Form · route	Labeler	Product NDC
Phenterminephentermine hydrochloride	Phentermine hydrochloride 30 mg/1	CapsuleOral	Aurolife Pharma, LLC	13107-106